India to United States: Efavirenz Export Trade Route
India has recorded 43 verified shipments of Efavirenz exported to United States, representing a combined trade value of $1.0M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $23.3K USD. The leading Indian exporter is AUROBINDO PHARMA LIMITED, which accounts for 25% of total export value with 8 shipments worth $252.4K USD. On the buying side, AUROLOGISTICS LLC (AUROBINDO PHARMA is the largest importer in United States with $183.6K USD in purchases. The top 3 suppliers — AUROBINDO PHARMA LIMITED, ANNORA PHARMA PRIVATE LIMITED, LAURUS LABS LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Efavirenz corridor is one of India's established pharmaceutical export routes, with 43 shipments documented worth a combined $1.0M USD. The route is dominated by AUROBINDO PHARMA LIMITED, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's efavirenz manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $23.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with efavirenz's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 23.9%, placing it at rank #2 among India's top efavirenz export destinations globally.
On the import side, key buyers of Indian efavirenz in United States include AUROLOGISTICS LLC (AUROBINDO PHARMA, Laurus Generics Inc, TO THE ORDER OF and 13 others. AUROLOGISTICS LLC (AUROBINDO PHARMA is the single largest importer with 7 shipments valued at $183.6K USD.
